We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > therapy

News List

AbbVie reports 99% cure rate for pan-genotypic Hep C therapy pharmatimes
April 24, 2017
AbbVie has released late-stage clinical data showing high cure rates for its experimental ribavirin-free hepatitis C therapy ...
Allergan and Novartis join forces to develop NASH combo therapy pharmafile
April 19, 2017
Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis (NASH), evaluating two of their treatments as a combination therapy.
FDA Grants Breakthrough Therapy Designation for Rituxan®in Pemphigus Vulgaris americanpharmaceuticalreview
March 27, 2017
Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to Rituxan® (rituximab) for pemphigus vulgaris...
Cancer clinic turns to crowdfunding to boost therapy access pharmaceutical-technology
March 14, 2017
A cancer clinic based in London has taken the unprecedented step of launching a crowdfunding appeal striving to raise ...
Regenerative medicine market worth US$38.7 billion by 2021 pharmaasia
February 23, 2017
An overview of the major drivers and challenges impacting the Regenerative medicine market along with market share analysis

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page